Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$276M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Prudential Financial
PRU
|
+$134M |
| 4 |
Walmart Inc
WMT
|
+$119M |
| 5 |
Altria Group
MO
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$343M |
| 2 |
Microsoft
MSFT
|
+$286M |
| 3 |
Coca-Cola
KO
|
+$270M |
| 4 |
DuPont de Nemours
DD
|
+$262M |
| 5 |
Johnson & Johnson
JNJ
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.14% |
| 2 | Financials | 15% |
| 3 | Healthcare | 12.28% |
| 4 | Industrials | 11.29% |
| 5 | Consumer Discretionary | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Waterstone Financial
WSBF
$370M
| $2.31M | ﹤0.01% |
133,289
+10,996
| +9% | +$191K |
|
2277
Mesa Laboratories
MLAB
$564M
| $2.3M | ﹤0.01% |
15,491
+1,268
| +9% | +$173K |
|
|
BGFV
2278
DELISTED
Big 5 Sporting Goods
BGFV
| $2.29M | ﹤0.01% |
315,354
+88,740
| +39% | +$561K |
|
2279
CorVel
CRVL
$3.06B
| $2.29M | ﹤0.01% |
135,669
+18,408
| +16% | +$312K |
|
|
VBTX
2280
DELISTED
Veritex Holdings
VBTX
| $2.29M | ﹤0.01% |
82,613
+13,882
| +20% | +$392K |
|
|
YELL
2281
DELISTED
Yellow Corporation Common Stock
YELL
| $2.28M | ﹤0.01% |
258,251
+21,500
| +9% | +$254K |
|
|
BVH
2282
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $2.27M | ﹤0.01% |
49,381
+2,225
| +5% | +$99K |
|
2283
Accuray
ARAY
$32M
| $2.27M | ﹤0.01% |
453,325
+31,080
| +7% | +$163K |
|
2284
Applied Optoelectronics
AAOI
$7.57B
| $2.26M | ﹤0.01% |
90,317
-17,879
| -17% | -$556K |
|
2285
Karyopharm Therapeutics
KPTI
$43.5M
| $2.26M | ﹤0.01% |
11,213
+1,194
| +12% | +$238K |
|
|
BHVN
2286
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.26M | ﹤0.01% |
87,642
+47,505
| +118% | +$1.42M |
|
|
APTI
2287
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $2.24M | ﹤0.01% |
79,138
+39,538
| +100% | +$1.06M |
|
2288
Monarch Casino & Resort
MCRI
$2.2B
| $2.24M | ﹤0.01% |
53,006
+6,221
| +13% | +$273K |
|
|
NXEO
2289
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $2.24M | ﹤0.01% |
209,459
+19,642
| +10% | +$191K |
|
|
SGYP
2290
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $2.24M | ﹤0.01% |
1,223,644
+172,236
| +16% | +$364K |
|
2291
NovoCure
NVCR
$1.73B
| $2.24M | ﹤0.01% |
102,600
+3,500
| +4% | +$75.3K |
|
|
LFIN
2292
DELISTED
LongFin Corp Class A Common Stock
LFIN
| $2.24M | ﹤0.01% |
+129,527
| New | +$5.45M |
|
2293
Tactile Systems Technology
TCMD
$635M
| $2.23M | ﹤0.01% |
70,134
+8,807
| +14% | +$272K |
|
|
EGL
2294
DELISTED
Engility Holdings, Inc.
EGL
| $2.22M | ﹤0.01% |
91,106
+2,720
| +3% | +$71.4K |
|
2295
AppFolio
APPF
$6.38B
| $2.22M | ﹤0.01% |
54,327
+34,238
| +170% | +$1.42M |
|
2296
Tredegar Corp
TG
$265M
| $2.21M | ﹤0.01% |
123,363
+7,094
| +6% | +$128K |
|
2297
Plug Power
PLUG
$2.87B
| $2.21M | ﹤0.01% |
1,168,416
+35,299
| +3% | +$71.1K |
|
2298
Midland States Bancorp
MSBI
$699M
| $2.21M | ﹤0.01% |
69,861
+29,536
| +73% | +$949K |
|
2299
Aclaris Therapeutics
ACRS
$726M
| $2.2M | ﹤0.01% |
125,569
+3,802
| +3% | +$80.6K |
|
|
KERX
2300
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $2.2M | ﹤0.01% |
536,951
+17,620
| +3% | +$82K |
|
Similar funds
Charles Schwab's Q1 2018 Portfolio in Review
As of Q1 2018, Charles Schwab held 3,114 positions worth $129B, up 2% from $126B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.79B of net new capital in Q1 2018, opening 56 new positions and adding to 2,372 existing holdings. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 313,956 shares worth $16.6M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Boeing, an estimated $343M trimmed.
- Charles Schwab's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 313,956 shares worth $16.6M.
- Charles Schwab added most to Union Pacific in Q1 2018, an estimated $276M increase.
- Charles Schwab's biggest Q1 2018 reduction was Boeing, cutting an estimated $343M.
- Charles Schwab fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $42.1M.
- Charles Schwab's ten largest holdings make up 14% of its $129B portfolio in Q1 2018.
- Charles Schwab opened 56 new positions and closed 43 in Q1 2018.
- Charles Schwab's portfolio value rose 2% quarter-over-quarter to $129B.
Based on Charles Schwab's 13F filing for Q1 2018, filed 7 May 2018.